Perspective treatments for triple-negative breast cancer

Abstract
Description
Subject(s)
triple negative breast carcinoma, platinum derivates, olaparib, bevacizumab, eribulin, pembrolizumab.
Citation
ISSN
1802-4475
ISBN
Collections